Ligand profile
ZINC5462362
Virtual-screening candidate from ZINC.
Bound to: VK055_3062 — aspartate kinase, monofunctional class
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC5462362- UniProt (similar protein)
O69077- Tanimoto
- 0.500
- Target protein
- VK055_3062
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 182.2
- −1 ≤ LogP ≤ 5 -3.49
- MW ≤ 500 Da 321.3
- LogP ≤ 5 -3.49
- H-bond donors ≤ 5 7
- H-bond acceptors ≤ 10 7
- Rotatable bonds ≤ 10 8
- TPSA ≤ 140 Ų 182.2
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
C[C@@H](O)[C@H](NC(=O)[C@@H](NC(=O)[C@H](N)[C@@H](C)O)[C@@H](C)O)C(=O)OC[C@@H](O)[C@H](NC(=O)[C@@H](NC(=O)[C@H](N)[C@@H](C)O)[C@@H](C)O)C(=O)O
InChI=1S/C12H23N3O7/c1-4(16)7(13)10(19)14-8(5(2)17)11(20)15-9(6(3)18)12(21)22/h4-9,16-18H,13H2,1-3H3,(H,14,19)(H,15,20)(H,21,22)/t4-,5-,6-,7-,8+,9+/m1/s1InChI=1S/C12H23N3O7/c1-4(16)7(13)10(19)14-8(5(2)17)11(20)15-9(6(3)18)12(21)22/h4-9,16-18H,13H2,1-3H3,(H,14,19)(H,15,20)(H,21,22)/t4-,5-,6-,7-,8+,9+/m1/s1
COYHRQWNJDJCNA-JTMCIWCCSA-NCOYHRQWNJDJCNA-JTMCIWCCSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Query
- THR
- Homolog
- O69077
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC5462362 →
- ZINC ZINC20 ZINC5462362 →
- UniProt UniProt O69077 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC5462362”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_3062.
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).